269 related articles for article (PubMed ID: 8622876)
1. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
2. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R
Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693
[TBL] [Abstract][Full Text] [Related]
3. Analysis of candidate gene co-amplification with MYCN in neuroblastoma.
George RE; Kenyon R; McGuckin AG; Kohl N; Kogner P; Christiansen H; Pearson AD; Lunec J
Eur J Cancer; 1997 Oct; 33(12):2037-42. PubMed ID: 9516849
[TBL] [Abstract][Full Text] [Related]
4. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN.
Kuroda H; White PS; Sulman EP; Manohar CF; Reiter JL; Cohn SL; Brodeur GM
Oncogene; 1996 Oct; 13(7):1561-5. PubMed ID: 8875996
[TBL] [Abstract][Full Text] [Related]
5. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
[TBL] [Abstract][Full Text] [Related]
6. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus.
Noguchi T; Akiyama K; Yokoyama M; Kanda N; Matsunaga T; Nishi Y
Genes Chromosomes Cancer; 1996 Feb; 15(2):129-33. PubMed ID: 8834177
[TBL] [Abstract][Full Text] [Related]
7. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
Amler LC; Schürmann J; Schwab M
Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178
[TBL] [Abstract][Full Text] [Related]
8. Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.
Tonin PN; Yeger H; Stallings RL; Srinivasan PR; Lewis WH
Oncogene; 1989 Sep; 4(9):1117-21. PubMed ID: 2780050
[TBL] [Abstract][Full Text] [Related]
9. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
10. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction.
Gilbert J; Norris MD; Haber M; Kavallaris M; Marshall GM; Stewart BW
Mol Cell Probes; 1993 Jun; 7(3):227-34. PubMed ID: 8366868
[TBL] [Abstract][Full Text] [Related]
11. Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.
Kaneko S; Ohira M; Nakamura Y; Isogai E; Nakagawara A; Kaneko M
J Cancer Res Clin Oncol; 2007 Mar; 133(3):185-92. PubMed ID: 17028906
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
14. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
15. myc gene amplification and expression in primary human neuroblastoma.
Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
[TBL] [Abstract][Full Text] [Related]
16. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
[TBL] [Abstract][Full Text] [Related]
17. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
18. Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.
Ask A; Persson L; Rehnholm A; Frostesjö L; Holm I; Heby O
Cancer Res; 1993 Nov; 53(21):5262-8. PubMed ID: 8221660
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines.
Godbout R; Packer M; Bie W
J Biol Chem; 1998 Aug; 273(33):21161-8. PubMed ID: 9694872
[TBL] [Abstract][Full Text] [Related]
20. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas.
Shiloh Y; Korf B; Kohl NE; Sakai K; Brodeur GM; Harris P; Kanda N; Seeger RC; Alt F; Latt SA
Cancer Res; 1986 Oct; 46(10):5297-301. PubMed ID: 3756879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
